A Phase 2a Dose Escalation Study With SLV334 in Patients With Traumatic Brain Injury.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
A Randomized, Double Blind, Placebo Controlled, Phase 2 Dose Escalation Study to Investigate the Safety and Pharmacokinetics after Single and Multiple I.V. Doses of SLV334 in Sequential Cohorts of Patients with Moderate and Severe Traumatic Brain Injury.
Epistemonikos ID: 313376a4ccf1e6e6a9118c470c8c659e434a01b3
First added on: May 05, 2024